Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study
出版年份 2016 全文链接
标题
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study
作者
关键词
Liraglutide, Cardiovascular risk, Carotid intima-media thickness, Metabolic syndrome
出版物
Cardiovascular Diabetology
Volume 15, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-12-03
DOI
10.1186/s12933-016-0480-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma Apolipoprotein C-III Levels, Triglycerides, and Coronary Artery Calcification in Type 2 DiabeticsSignificance
- (2015) Arman Qamar et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 and Ghrelin Levels in Patients with Type 2 Diabetes: A Prospective Pilot Study
- (2015) Manfredi Rizzo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease
- (2015) Alper Sonmez et al. Lipids in Health and Disease
- Anti-atherosclerotic effects of the glucagon-like peptide-1 (GLP-1) based therapies in patients with type 2 Diabetes Mellitus: A meta-analysis
- (2015) Xiaoyan Song et al. Scientific Reports
- Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study
- (2014) Manfredi Rizzo et al. Cardiovascular Diabetology
- Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study
- (2014) Maria-Agata Miselli et al. Cardiovascular Diabetology
- Liraglutide as a Potentially Useful Agent for Regulating Appetite in Diabetic Patients with Hypothalamic Hyperphagia and Obesity
- (2014) Takao Ando et al. INTERNAL MEDICINE
- Nonalcoholic Fatty Liver Disease Is Associated With Increased Carotid Intima-Media Thickness Only in Type 2 Diabetic Subjects With Insulin Resistance
- (2014) Soo-Kyung Kim et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Oxidative stress and triglycerides as predictors of subclinical atherosclerosis in prediabetes
- (2014) Hayder A. Al-Aubaidy et al. REDOX REPORT
- Long-term impact of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight and glycemic control in Japanese type 2 diabetes: an observational study
- (2014) Kana Inoue et al. Diabetology & Metabolic Syndrome
- Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines
- (2013) Jong-Youn Kim et al. Cardiovascular Diabetology
- The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspective
- (2013) Manfredi Rizzo et al. Clinical Lipidology
- The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE−/− mouse model
- (2013) Tracey Gaspari et al. Diabetes & Vascular Disease Research
- Benefits of Liraglutide Treatment in Overweight and Obese Older Individuals With Prediabetes
- (2013) S. H. Kim et al. DIABETES CARE
- Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
- (2013) E. R. Seaquist et al. DIABETES CARE
- GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases
- (2013) Flavius Zoicas et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pioglitazone and metformin are equally effective in reduction of chemerin in patients with type 2 diabetes
- (2013) Alireza Esteghamati et al. Journal of Diabetes Investigation
- Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis
- (2012) J. Plutzky et al. Canadian Journal of Diabetes
- Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity
- (2012) Chun-jun Li et al. Cardiovascular Diabetology
- Editorial [ Reducing Cardiovascular Risk: Is Low-Density Lipoprotein-Cholesterol (LDL-C) Lowering Enough? ]
- (2012) Michael S. Kostapanos et al. Current Vascular Pharmacology
- Cardiovascular effects of GLP-1 and GLP-1-based therapies: implications for the cardiovascular continuum in diabetes?
- (2012) M. Burgmaier et al. DIABETIC MEDICINE
- The metabolic syndrome influences the response to incretin-based therapies
- (2011) Gian Paolo Fadini et al. ACTA DIABETOLOGICA
- Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
- (2011) A Astrup et al. INTERNATIONAL JOURNAL OF OBESITY
- A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus
- (2010) Eduard Montanya et al. CLINICAL THERAPEUTICS
- Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study
- (2010) Egle Corrado et al. CORONARY ARTERY DISEASE
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice
- (2009) M. H. Noyan-Ashraf et al. DIABETES
- Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: A post-hoc analysis of the BIGPRO1 trial
- (2009) A. Fontbonne et al. DIABETES & METABOLISM
- Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
- (2009) B. Zinman et al. DIABETES CARE
- Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors
- (2009) Manfredi Rizzo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
- (2009) Arne Astrup et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now